Iovance Grants 93,340 Inducement Stock Options to 13 New Employees

Iovance Biotherapeutics, Inc. announced the grant of inducement stock options for an aggregate of 93,340 shares of its common stock to thirteen new, non-executive employees on May 21, 2026. These awards were issued under the company's Amended and Restated 2021 Inducement Plan, adhering to Nasdaq Listing Rule 5635(c)(4). Each option has an exercise price of $3.70, matching the closing price on the grant date, and vests over a three-year period, subject to continued employment.